George Shenouda
Papers
1
Total Citations
10
H-Index
1
About
Dr. George Shenouda is a leading oncologist whose research focuses on the intersection of surgical innovation and chemotherapy for head and neck cancers, particularly human papillomavirus (HPV)-related oropharyngeal squamous cell carcinoma (OPSCC). His most impactful work, "Neoadjuvant Chemotherapy and Transoral Robotic Surgery for Human Papillomavirus–Related Oropharyngeal Cancer" (2024, 10 citations), addresses a critical challenge in the field: reducing distant metastasis (DM)—the leading cause of death in these patients—while minimizing treatment-related toxicities. By pioneering a strategy that combines neoadjuvant chemotherapy with transoral robotic surgery, Dr. Shenouda aims to improve survival outcomes and quality of life. His contributions are vital for developing less morbid, more effective therapies for HPV-positive OPSCC, a growing patient population. With a career dedicated to translating clinical trials into practice, Dr. Shenouda’s work has shaped modern approaches to de-escalating treatment intensity without compromising oncologic control. His research continues to influence how clinicians balance efficacy and toxicity, making him a key figure in head and neck oncology.
Research Focus
Key Achievements
Top Papers
- 1